Mark van Oene
Chief Operating Officer at PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Net worth: 6 M $ as of 2024-03-30
Mark van Oene active positions
| Companies | Position | Start | End |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Chief Operating Officer | 2021-01-07 | - |
Illumina Cambridge Ltd.
 Illumina Cambridge Ltd. Miscellaneous Commercial ServicesCommercial Services Illumina Cambridge Ltd. develops, manufactures and commercializes instruments, consumables and technologies for the analysis of DNA and genetic variation. The company was founded in 1998 and is headquartered in Saffron Walden, the United Kingdom. | Director/Board Member | - | - |
BlueGnome Ltd.
 BlueGnome Ltd. Packaged SoftwareTechnology Services BlueGnome Ltd. provides application software services. It offers solutions for detection of copy number variation in the human genome. The firm's main application areas include analysis of constitutional samples to elucidate genetic disease, investigation of haematological malignancies and aneuploidy screening of single cells. The company was founded on October 15, 2001 and is headquartered in Saffron Walden, the United Kingdom. | Director/Board Member | 2018-01-21 | - |
Dante Labs, Inc.
 Dante Labs, Inc. Medical/Nursing ServicesHealth Services Dante Labs, Inc. operates as a genetic testing laboratory. The company was founded by Andrea Riposati and Mattia Capulli in 2016 and is headquartered in New York, NY. | Director/Board Member | 2021-08-23 | - |
Career history of Mark van Oene
Former positions of Mark van Oene
| Companies | Position | Start | End |
|---|---|---|---|
Ellipsis Biotherapeutics Corp.
 Ellipsis Biotherapeutics Corp. Miscellaneous Commercial ServicesCommercial Services Part of DNAPrint Genomics, Inc., Ellipsis Biotherapeutics Corp. provides commercial genotyping services and gene research. The private company is based in Toronto, Canada. Ellipsis Biotherapeutics was acquired by DNAPrint Genomics, Inc. on December 19, 2005 for $0.11 million. | Corporate Officer/Principal | - | - |
| ILLUMINA, INC. | Corporate Officer/Principal | 2013-12-31 | - |
| Sales & Marketing | 2011-12-31 | 2013-12-31 |
Training of Mark van Oene
| University of Toronto | Doctorate Degree |
| University of Western Ontario | Undergraduate Degree |
Statistics
International
| United States | 4 |
| Canada | 4 |
| United Kingdom | 3 |
Operational
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
| Sales & Marketing | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ILLUMINA, INC. | Health Technology |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Health Technology |
| Private companies | 4 |
|---|---|
BlueGnome Ltd.
BlueGnome Ltd. Packaged SoftwareTechnology Services BlueGnome Ltd. provides application software services. It offers solutions for detection of copy number variation in the human genome. The firm's main application areas include analysis of constitutional samples to elucidate genetic disease, investigation of haematological malignancies and aneuploidy screening of single cells. The company was founded on October 15, 2001 and is headquartered in Saffron Walden, the United Kingdom. | Technology Services |
Ellipsis Biotherapeutics Corp.
Ellipsis Biotherapeutics Corp. Miscellaneous Commercial ServicesCommercial Services Part of DNAPrint Genomics, Inc., Ellipsis Biotherapeutics Corp. provides commercial genotyping services and gene research. The private company is based in Toronto, Canada. Ellipsis Biotherapeutics was acquired by DNAPrint Genomics, Inc. on December 19, 2005 for $0.11 million. | Commercial Services |
Dante Labs, Inc.
Dante Labs, Inc. Medical/Nursing ServicesHealth Services Dante Labs, Inc. operates as a genetic testing laboratory. The company was founded by Andrea Riposati and Mattia Capulli in 2016 and is headquartered in New York, NY. | Health Services |
Illumina Cambridge Ltd.
Illumina Cambridge Ltd. Miscellaneous Commercial ServicesCommercial Services Illumina Cambridge Ltd. develops, manufactures and commercializes instruments, consumables and technologies for the analysis of DNA and genetic variation. The company was founded in 1998 and is headquartered in Saffron Walden, the United Kingdom. | Commercial Services |
- Stock Market
- Insiders
- Mark van Oene
- Experience
